Jonathan G. Drachman - 04 May 2021 Form 4/A - Amendment Insider Report for Harpoon Therapeutics, Inc.

Role
Director
Signature
/s/ Jonathan Drachman by Christopher Whitmore, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
04 May 2021
Net transactions value
$0
Form type
4/A - Amendment
Filing time
14 May 2021, 19:59:58 UTC
Date Of Original Report
07 May 2021
Next filing
07 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HARP Director Stock Option (Right to Buy) Award $0 +10,167 $0.000000 10,167 04 May 2021 Common Stock 10,167 $23.20 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was erroneously reported with a price of $22.50 on the original Form 4 filed on May 7, 2021 due to an administrative error.
F2 The stock option will fully vest and become exercisable on May 3, 2022, subject to the continuous service of the Reporting Person with the Issuer on such date. The original Form 4 filed on May 7, 2021 erroneously reported this vesting date as May 4, 2022.